Nathaniel E. Clark

706 total citations
19 papers, 405 citations indexed

About

Nathaniel E. Clark is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Nathaniel E. Clark has authored 19 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in Nathaniel E. Clark's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and RNA regulation and disease (5 papers). Nathaniel E. Clark is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and RNA regulation and disease (5 papers). Nathaniel E. Clark collaborates with scholars based in United States, Canada and United Kingdom. Nathaniel E. Clark's co-authors include Scott C. Garman, A.I. Guce, Dina R. Ivanen, Harry Brumer, Anna A. Kulminskaya, Eric N. Salgado, Masad J. Damha, Daniel Best, George W. J. Fleet and P. John Hart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Nathaniel E. Clark

18 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathaniel E. Clark United States 10 227 143 142 67 61 19 405
Supansa Pantoom Germany 12 213 0.9× 47 0.3× 61 0.4× 66 1.0× 129 2.1× 15 372
Cecilia D’Alessio Argentina 14 448 2.0× 132 0.9× 77 0.5× 240 3.6× 81 1.3× 25 613
B. Overdijk Netherlands 14 346 1.5× 110 0.8× 137 1.0× 43 0.6× 36 0.6× 27 468
Tatyana Leonova United States 11 305 1.3× 74 0.5× 214 1.5× 127 1.9× 134 2.2× 16 533
David J. Wasilko United States 8 272 1.2× 51 0.4× 19 0.1× 69 1.0× 49 0.8× 11 475
M. Anderson Australia 7 211 0.9× 59 0.4× 109 0.8× 93 1.4× 46 0.8× 10 375
Hiroto Hirayama Japan 13 350 1.5× 115 0.8× 46 0.3× 203 3.0× 29 0.5× 30 449
Esko Jd Sweden 12 259 1.1× 71 0.5× 25 0.2× 69 1.0× 39 0.6× 48 349
Khanita Karaveg United States 10 502 2.2× 275 1.9× 95 0.7× 232 3.5× 74 1.2× 12 678
Jane R. Scocca United States 11 422 1.9× 187 1.3× 52 0.4× 54 0.8× 50 0.8× 22 537

Countries citing papers authored by Nathaniel E. Clark

Since Specialization
Citations

This map shows the geographic impact of Nathaniel E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel E. Clark more than expected).

Fields of papers citing papers by Nathaniel E. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel E. Clark. The network helps show where Nathaniel E. Clark may publish in the future.

Co-authorship network of co-authors of Nathaniel E. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel E. Clark. A scholar is included among the top collaborators of Nathaniel E. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel E. Clark. Nathaniel E. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Clark, Nathaniel E., et al.. (2025). Removal of dsRNA byproducts using affinity chromatography. Molecular Therapy — Nucleic Acids. 36(2). 102549–102549. 1 indexed citations
2.
Sherry, Lee, Keith Grehan, Mohammad W. Bahar, et al.. (2025). Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. npj Vaccines. 10(1). 64–64.
3.
Clark, Nathaniel E., Chaorui Duan, Allison J. Taggart, et al.. (2024). The debranching enzyme Dbr1 regulates lariat turnover and intron splicing. Nature Communications. 15(1). 4617–4617. 8 indexed citations
4.
Clark, Nathaniel E., et al.. (2024). An immuno‐northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNA. Electrophoresis. 45(17-18). 1546–1554. 4 indexed citations
5.
Clark, Nathaniel E., Adam Katolik, E. Murphy, et al.. (2023). Activation of human RNA lariat debranching enzyme Dbr1 by binding protein TTDN1 occurs though an intrinsically disordered C-terminal domain. Journal of Biological Chemistry. 299(9). 105100–105100. 3 indexed citations
6.
Clark, Nathaniel E., Adam Katolik, Allison J. Taggart, et al.. (2022). Metal content and kinetic properties of yeast RNA lariat debranching enzyme Dbr1. RNA. 28(7). 927–936. 6 indexed citations
7.
Clark, Nathaniel E., Adam Katolik, Christoph Schorl, et al.. (2022). Crystal Structure of the RNA Lariat Debranching Enzyme Dbr1 with Hydrolyzed Phosphorothioate RNA Product. Biochemistry. 61(24). 2933–2939. 2 indexed citations
8.
Taylor, Alexander B., Xiaohang Cao, Nathaniel E. Clark, et al.. (2017). Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy. Journal of Biological Chemistry. 292(27). 11154–11164. 21 indexed citations
9.
Katolik, Adam, et al.. (2017). Fluorescent Branched RNAs for High-Throughput Analysis of Dbr1 Enzyme Kinetics and Inhibition. ACS Chemical Biology. 12(3). 622–627. 9 indexed citations
10.
Clark, Nathaniel E., Adam Katolik, Alexander B. Taylor, et al.. (2016). Metal dependence and branched RNA cocrystal structures of the RNA lariat debranching enzyme Dbr1. Proceedings of the National Academy of Sciences. 113(51). 14727–14732. 21 indexed citations
11.
Katolik, Adam, Nathaniel E. Clark, Eric Montemayor, et al.. (2015). Design, Synthesis, and Properties of Phosphoramidate 2′,5′-Linked Branched RNA: Toward the Rational Design of Inhibitors of the RNA Lariat Debranching Enzyme. The Journal of Organic Chemistry. 80(20). 10108–10118. 7 indexed citations
12.
Montemayor, Eric, Adam Katolik, Nathaniel E. Clark, et al.. (2014). Structural basis of lariat RNA recognition by the intron debranching enzyme Dbr1. Nucleic Acids Research. 42(16). 10845–10855. 33 indexed citations
13.
Garman, Scott C., et al.. (2013). The molecular basis of pharmacological chaperoning in human alpha-galactosidase. Molecular Genetics and Metabolism. 108(2). S41–S42. 1 indexed citations
14.
Clark, Nathaniel E., et al.. (2012). Adaptor-Dependent Degradation of a Cell-Cycle Regulator Uses a Unique Substrate Architecture. Structure. 20(7). 1223–1232. 20 indexed citations
15.
Clark, Nathaniel E., et al.. (2012). Pharmacological chaperones for human α- N -acetylgalactosaminidase. Proceedings of the National Academy of Sciences. 109(43). 17400–17405. 46 indexed citations
16.
Guce, A.I., et al.. (2011). The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase. Chemistry & Biology. 18(12). 1521–1526. 60 indexed citations
17.
Tomašić, Ivan, et al.. (2010). Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases. Journal of Biological Chemistry. 285(28). 21560–21566. 21 indexed citations
18.
Clark, Nathaniel E. & Scott C. Garman. (2009). The 1.9 Å Structure of Human α-N-Acetylgalactosaminidase: The Molecular Basis of Schindler and Kanzaki Diseases. Journal of Molecular Biology. 393(2). 435–447. 43 indexed citations
19.
Guce, A.I., Nathaniel E. Clark, Eric N. Salgado, et al.. (2009). Catalytic Mechanism of Human α-Galactosidase. Journal of Biological Chemistry. 285(6). 3625–3632. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Supansa Pantoom Breakdown of academic impact, for papers by Cecilia D’Alessio Breakdown of academic impact, for papers by B. Overdijk Breakdown of academic impact, for papers by Tatyana Leonova Breakdown of academic impact, for papers by David J. Wasilko Breakdown of academic impact, for papers by M. Anderson Breakdown of academic impact, for papers by Hiroto Hirayama Breakdown of academic impact, for papers by Esko Jd Breakdown of academic impact, for papers by Khanita Karaveg Breakdown of academic impact, for papers by Jane R. Scocca
Rankless by CCL
2026